My spin;
1. Research interest in peptide libraries was getting so big they had to set up the Cambridge option.
2.Big Pharma patent expiry cliff/lack of blockbuster drugs- already well known providing external opportunities with companies like PYC.
3. Billions of "options" generated a process to speed up analysis from years to weeks.
4.New Discussions gathering momentum- anyone know which Pharma Company based in La Jolla, San Diego - sounds like clue.
Might have been a good decision to buy PYCO this morning. Sounds like a break out year 2011.
Thoughts everyone?
Ramses
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |